14 research outputs found
Π Π΅ΠΏΡΠΎΠ΄ΡΠΊΡΠΈΠ²Π½ΠΎΠ΅ Π·Π΄ΠΎΡΠΎΠ²ΡΠ΅ ΠΌΡΠΆΡΠΈΠ½ Π² ΠΏΠ°ΡΠ°Ρ , ΡΡΡΠ°Π΄Π°ΡΡΠΈΡ Π½Π΅Π²ΡΠ½Π°ΡΠΈΠ²Π°Π½ΠΈΠ΅ΠΌ Π±Π΅ΡΠ΅ΠΌΠ΅Π½Π½ΠΎΡΡΠΈ
In the context of current demographic situation the problem of miscarriage has become especially acute. Traditionally various aspects of miscarriage and the preterm labor have been viewed through the prism of the woman's health. At the same time, according to the present reproductive medicine, a proper approach to this problem includes taking into account the state of health of both future parents. In contrast to infertility, male reproductive health in couples, suffering from miscarriage, and its contribution to the outcome of pregnancy, ending without childbirth, hasn't been determined yet. The article includes the results of studying reproductive health in 62 men β husbands of women, suffering from miscarriage at different terms. The role of chronic viral infection as a cause of spermatogenesis disturbances has been shown.Π ΡΠ°Π·ΡΠ΅Π·Π΅ ΡΠΎΠ²ΡΠ΅ΠΌΠ΅Π½Π½ΠΎΠΉ Π΄Π΅ΠΌΠΎΠ³ΡΠ°ΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΠΈΡΡΠ°ΡΠΈΠΈ ΠΏΡΠΎΠ±Π»Π΅ΠΌΠ° Π½Π΅Π²ΡΠ½Π°ΡΠΈΠ²Π°Π½ΠΈΡ Π±Π΅ΡΠ΅ΠΌΠ΅Π½Π½ΠΎΡΡΠΈ ΠΏΡΠΈΠΎΠ±ΡΠ΅Π»Π° ΠΎΡΠΎΠ±ΡΡ ΠΎΡΡΡΠΎΡΡ. Π’ΡΠ°Π΄ΠΈΡΠΈΠΎΠ½Π½ΠΎ ΡΠ°Π·Π»ΠΈΡΠ½ΡΠ΅ Π°ΡΠΏΠ΅ΠΊΡΡ Π½Π΅Π²ΡΠ½Π°ΡΠΈΠ²Π°Π½ΠΈΡ ΠΈ Π½Π΅Π΄ΠΎΠ½Π°ΡΠΈΠ²Π°Π½ΠΈΡ Π±Π΅ΡΠ΅ΠΌΠ΅Π½Π½ΠΎΡΡΠΈ ΠΏΡΠΈΠ½ΡΡΠΎ ΡΠ°ΡΡΠΌΠ°ΡΡΠΈΠ²Π°ΡΡ ΡΠΊΠ²ΠΎΠ·Ρ ΠΏΡΠΈΠ·ΠΌΡ Π·Π΄ΠΎΡΠΎΠ²ΡΡ ΠΆΠ΅Π½ΡΠΈΠ½Ρ-ΠΌΠ°ΡΠ΅ΡΠΈ. ΠΠΌΠ΅ΡΡΠ΅ Ρ ΡΠ΅ΠΌ ΡΠΎΠ²ΡΠ΅ΠΌΠ΅Π½Π½ΡΠΉ ΡΠ΅ΠΏΡΠΎΠ΄ΡΠΊΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠΉ ΠΏΠΎΠ΄Ρ
ΠΎΠ΄ ΠΏΡΠ΅Π΄ΡΡΠΌΠ°ΡΡΠΈΠ²Π°Π΅Ρ Π½Π΅ΠΎΠ±Ρ
ΠΎΠ΄ΠΈΠΌΠΎΡΡΡ ΡΡΠ΅ΡΠ° Π·Π΄ΠΎΡΠΎΠ²ΡΡ ΠΎΠ±ΠΎΠΈΡ
Π±ΡΠ΄ΡΡΠΈΡ
ΡΠΎΠ΄ΠΈΡΠ΅Π»Π΅ΠΉ. Π ΠΏΡΠΎΡΠΈΠ²ΠΎΠ²Π΅Ρ Π±Π΅ΡΠΏΠ»ΠΎΠ΄ΠΈΡ, ΡΠ΅ΠΏΡΠΎΠ΄ΡΠΊΡΠΈΠ²Π½ΠΎΠ΅ Π·Π΄ΠΎΡΠΎΠ²ΡΠ΅ ΠΌΡΠΆΡΠΈΠ½ Π² ΠΏΠ°ΡΠ°Ρ
, ΡΡΡΠ°Π΄Π°ΡΡΠΈΡ
Π½Π΅Π²ΡΠ½Π°ΡΠΈΠ²Π°Π½ΠΈΠ΅ΠΌ, ΠΏΡΠ°ΠΊΡΠΈΡΠ΅ΡΠΊΠΈ Π½Π΅ ΠΈΠ·ΡΡΠ΅Π½ΠΎ, ΠΈ Π²ΠΊΠ»Π°Π΄ Π΅Π³ΠΎ Π½Π°ΡΡΡΠ΅Π½ΠΈΠΉ Π² ΠΈΡΡ
ΠΎΠ΄ Π±Π΅ΡΠ΅ΠΌΠ΅Π½Π½ΠΎΡΡΠΈ, Π½Π΅ Π·Π°ΠΊΠΎΠ½ΡΠΈΠ²ΡΠ΅ΠΉΡΡ Π΄Π΅ΡΠΎΡΠΎΠΆΠ΄Π΅Π½ΠΈΠ΅ΠΌ, Π½Π΅ ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½. ΠΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½Ρ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΡ ΠΈΠ·ΡΡΠ΅Π½ΠΈΡ ΡΠ΅ΠΏΡΠΎΠ΄ΡΠΊΡΠΈΠ²Π½ΠΎΠ³ΠΎ Π·Π΄ΠΎΡΠΎΠ²ΡΡ 62 ΠΌΡΠΆΡΠΈΠ½, ΡΡΠΏΡΡΠ³ΠΎΠ² ΠΆΠ΅Π½ΡΠΈΠ½, ΡΡΡΠ°Π΄Π°ΡΡΠΈΡ
Π½Π΅Π²ΡΠ½Π°ΡΠΈΠ²Π°Π½ΠΈΠ΅ΠΌ Π±Π΅ΡΠ΅ΠΌΠ΅Π½Π½ΠΎΡΡΠΈ Π² ΡΠ°Π·Π»ΠΈΡΠ½ΠΎΠΌ ΡΡΠΎΠΊΠ΅. ΠΠΎΠΊΠ°Π·Π°Π½Π° ΡΠΎΠ»Ρ Ρ
ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΎΠΉ Π²ΠΈΡΡΡΠ½ΠΎΠΉ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΈ ΠΊΠ°ΠΊ ΠΏΡΠΈΡΠΈΠ½Ρ ΡΠ°Π·Π²ΠΈΡΠΈΡ Π½Π°ΡΡΡΠ΅Π½ΠΈΠΉ ΡΠΏΠ΅ΡΠΌΠ°ΡΠΎΠ³Π΅Π½Π΅Π·Π°
ΠΠΈΠ½Π΅ΠΊΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠ°Ρ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π΅ΠΌΠΎΡΡΡ ΠΈ ΡΠ΅ΠΏΡΠΎΠ΄ΡΠΊΡΠΈΠ²Π½ΡΠ΅ ΠΏΠΎΡΠ΅ΡΠΈ Π² Π ΠΎΡΡΠΈΠΈ Π² ΠΏΠ΅ΡΠ²ΠΎΠΉ Π΄Π΅ΠΊΠ°Π΄Π΅ XXI Π².
In the recent years the state of reproductive health of women in Russia has attracted a careful attention of scientists, clinicians and health professionals. The article includes the analysis of the Federal State Statistics Service data. Tendencies in gynecologic incidence for the recent 13 years have been revealed. The analysis of the structure of reproductive losses in the Russian Federation in 2009 has been carried out.Π‘ΠΎΡΡΠΎΡΠ½ΠΈΠ΅ ΡΠ΅ΠΏΡΠΎΠ΄ΡΠΊΡΠΈΠ²Π½ΠΎΠ³ΠΎ Π·Π΄ΠΎΡΠΎΠ²ΡΡ ΠΆΠ΅Π½ΡΠΈΠ½ Π ΠΎΡΡΠΈΠΈ Π² ΠΏΠΎΡΠ»Π΅Π΄Π½ΠΈΠ΅ Π³ΠΎΠ΄Ρ ΠΏΡΠΈΠ²Π»Π΅ΠΊΠ°Π΅Ρ ΠΏΡΠΈΡΡΠ°Π»ΡΠ½ΠΎΠ΅ Π²Π½ΠΈΠΌΠ°Π½ΠΈΠ΅ ΡΡΠ΅Π½ΡΡ
, ΠΊΠ»ΠΈΠ½ΠΈΡΠΈΡΡΠΎΠ² ΠΈ ΠΎΡΠ³Π°Π½ΠΈΠ·Π°ΡΠΎΡΠΎΠ² Π·Π΄ΡΠ°Π²ΠΎΠΎΡ
ΡΠ°Π½Π΅Π½ΠΈΡ. Π ΡΡΠ°ΡΡΠ΅ ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½ Π°Π½Π°Π»ΠΈΠ· Π΄Π°Π½Π½ΡΡ
Π ΠΎΡΡΡΠ°ΡΠ°, Π²ΡΡΠ²Π»Π΅Π½Ρ ΡΠ΅Π½Π΄Π΅Π½ΡΠΈΠΈ Π³ΠΈΠ½Π΅ΠΊΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠΉ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π΅ΠΌΠΎΡΡΠΈ Π·Π° ΠΏΠΎΡΠ»Π΅Π΄Π½ΠΈΠ΅ 13 Π»Π΅Ρ. ΠΡΠΎΠ²Π΅Π΄Π΅Π½ Π°Π½Π°Π»ΠΈΠ· ΡΡΡΡΠΊΡΡΡΡ ΡΠ΅ΠΏΡΠΎΠ΄ΡΠΊΡΠΈΠ²Π½ΡΡ
ΠΏΠΎΡΠ΅ΡΡ Π² Π Π€ Π·Π° 2009 Π³
Π Π΅Π³ΠΈΠΎΠ½Π°Π»ΡΠ½ΡΠ΅ ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΠΈ Π·Π΄ΠΎΡΠΎΠ²ΡΡ Π±Π΅ΡΠ΅ΠΌΠ΅Π½Π½ΡΡ ΠΆΠ΅Π½ΡΠΈΠ½, ΠΏΡΠΎΠΆΠΈΠ²Π°ΡΡΠΈΡ Π² ΠΠ°ΡΠ°ΡΠ°Π΅Π²ΠΎ-Π§Π΅ΡΠΊΠ΅ΡΡΠΊΠΎΠΉ Π Π΅ΡΠΏΡΠ±Π»ΠΈΠΊΠ΅ ΠΈ ΠΡΠΈΠΌΠΎΡΡΠΊΠΎΠΌ ΠΊΡΠ°Π΅
Due to the adverse demographic situation in the Russian Federation (Russian Federation) keep the urgency questions of protection of reproductive health of women. Its regional features are necessary for considering when developing regional programs on optimization of the specialized help to pregnant women. In article the comparative analysis of the main indicators of the statistical reporting of the Russian Federation, the Karachaevo-Circassian republic (KChR) and Primorsky Krai (personal computer), pregnant women characterizing health (The Russian Federal Service of State Statistics, in dynamics for 2005β2010 gg is presented.) It is revealed that, despite improvement of the majority of indicators, level of their population health in the Russian Federation remains low β at every third anemia, at everyone a heel β diseases of urinogenital system, at every tenth β diseases of system of blood circulation is registered. Feature of KChR is higher frequency of diseases of a thyroid gland and the venous complications tending to growth, low level of diseases of urinogenital system, and also growth of incidence by a preeklampsiya, eklampsiy at lower general frequency of complications of pregnancy hypostases, a proteinuria and gipertenzivny frustration. Regional indicators of the personal computer which distinguish lower frequency of diseases of system of blood circulation, venous complications and stably low level of complications of pregnancy a preeklampsiya, eklampsiy, as a whole more reflect the all-Russian tendencies. The problems demanding adoption of organizational decisions, threat of interruption of the pregnancy, which half of cases, irrespective of the region are, it is the share of terms of 22β37 weeks, and the diabetes complicating a current of a gestatsiya, incidence which in the Russian Fed-eration and in the personal computer steadily grows, and in KChR, despite decrease, disorder of an indicator still corresponds to the all-Russian.Π ΡΠ²ΡΠ·ΠΈ Ρ Π½Π΅Π±Π»Π°Π³ΠΎΠΏΡΠΈΡΡΠ½ΠΎΠΉ Π΄Π΅ΠΌΠΎΠ³ΡΠ°ΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΠΈΡΡΠ°ΡΠΈΠ΅ΠΉ Π² Π ΠΎΡΡΠΈΠΉΡΠΊΠΎΠΉ Π€Π΅Π΄Π΅ΡΠ°ΡΠΈΠΈ (Π Π€) ΡΠΎΡ
ΡΠ°Π½ΡΡΡ ΡΠ²ΠΎΡ Π°ΠΊΡΡΠ°Π»ΡΠ½ΠΎΡΡΡ Π²ΠΎΠΏΡΠΎΡΡ ΠΎΡ
ΡΠ°Π½Ρ ΡΠ΅ΠΏΡΠΎΠ΄ΡΠΊΡΠΈΠ²Π½ΠΎΠ³ΠΎ Π·Π΄ΠΎΡΠΎΠ²ΡΡ ΠΆΠ΅Π½ΡΠΈΠ½. ΠΠ³ΠΎ ΡΠ΅Π³ΠΈΠΎΠ½Π°Π»ΡΠ½ΡΠ΅ ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΠΈ Π½Π΅ΠΎΠ±Ρ
ΠΎΠ΄ΠΈΠΌΠΎ ΡΡΠΈΡΡΠ²Π°ΡΡ ΠΏΡΠΈ ΡΠ°Π·ΡΠ°Π±ΠΎΡΠΊΠ΅ ΡΠ΅Π³ΠΈΠΎΠ½Π°Π»ΡΠ½ΡΡ
ΠΏΡΠΎΠ³ΡΠ°ΠΌΠΌ ΠΏΠΎ ΠΎΠΏΡΠΈΠΌΠΈΠ·Π°ΡΠΈΠΈ ΡΠΏΠ΅ΡΠΈΠ°Π»ΠΈΠ·ΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠΉ ΠΏΠΎΠΌΠΎΡΠΈ Π±Π΅ΡΠ΅ΠΌΠ΅Π½Π½ΡΠΌ. Π ΡΡΠ°ΡΡΠ΅ ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½ ΡΡΠ°Π²Π½ΠΈΡΠ΅Π»ΡΠ½ΡΠΉ Π°Π½Π°Π»ΠΈΠ· ΠΎΡΠ½ΠΎΠ²Π½ΡΡ
ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Π΅ΠΉ ΡΡΠ°ΡΠΈΡΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΎΡΡΠ΅ΡΠ½ΠΎΡΡΠΈ Π Π€, ΠΠ°ΡΠ°ΡΠ°Π΅Π²ΠΎ-Π§Π΅ΡΠΊΠ΅ΡΡΠΊΠΎΠΉ ΡΠ΅ΡΠΏΡΠ±Π»ΠΈΠΊΠΈ (ΠΠ§Π ) ΠΈ ΠΡΠΈΠΌΠΎΡΡΠΊΠΎΠ³ΠΎ ΠΊΡΠ°Ρ (ΠΠ), Ρ
Π°ΡΠ°ΠΊΡΠ΅ΡΠΈΠ·ΡΡΡΠΈΡ
Π·Π΄ΠΎΡΠΎΠ²ΡΠ΅ Π±Π΅ΡΠ΅ΠΌΠ΅Π½Π½ΡΡ
ΠΆΠ΅Π½ΡΠΈΠ½ (Π ΠΎΡΡΡΠ°Ρ, Π² Π΄ΠΈΠ½Π°ΠΌΠΈΠΊΠ΅ Π·Π° 2005β2010 Π³Π³.). ΠΡΡΠ²Π»Π΅Π½ΠΎ, ΡΡΠΎ, Π½Π΅ΡΠΌΠΎΡΡΡ Π½Π° ΡΠ»ΡΡΡΠ΅Π½ΠΈΠ΅ Π±ΠΎΠ»ΡΡΠΈΠ½ΡΡΠ²Π° ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Π΅ΠΉ, ΡΡΠΎΠ²Π΅Π½Ρ ΠΈΡ
ΠΏΠΎΠΏΡΠ»ΡΡΠΈΠΎΠ½Π½ΠΎΠ³ΠΎ Π·Π΄ΠΎΡΠΎΠ²ΡΡ Π² Π Π€ ΠΎΡΡΠ°Π΅ΡΡΡ Π½ΠΈΠ·ΠΊΠΈΠΌ β Ρ ΠΊΠ°ΠΆΠ΄ΠΎΠΉ ΡΡΠ΅ΡΡΠ΅ΠΉ ΡΠ΅Π³ΠΈΡΡΡΠΈΡΡΠ΅ΡΡΡ Π°Π½Π΅ΠΌΠΈΡ, Ρ ΠΊΠ°ΠΆΠ΄ΠΎΠΉ ΠΏΡΡΠΎΠΉ β Π±ΠΎΠ»Π΅Π·Π½ΠΈ ΠΌΠΎΡΠ΅ΠΏΠΎΠ»ΠΎΠ²ΠΎΠΉ ΡΠΈΡΡΠ΅ΠΌΡ, Ρ ΠΊΠ°ΠΆΠ΄ΠΎΠΉ Π΄Π΅ΡΡΡΠΎΠΉ β Π±ΠΎΠ»Π΅Π·Π½ΠΈ ΡΠΈΡΡΠ΅ΠΌΡ ΠΊΡΠΎΠ²ΠΎΠΎΠ±ΡΠ°ΡΠ΅Π½ΠΈΡ. ΠΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΡΡ ΠΠ§Π ΡΠ²Π»ΡΠ΅ΡΡΡ Π±ΠΎΠ»Π΅Π΅ Π²ΡΡΠΎΠΊΠ°Ρ ΡΠ°ΡΡΠΎΡΠ° Π±ΠΎΠ»Π΅Π·Π½Π΅ΠΉ ΡΠΈΡΠΎΠ²ΠΈΠ΄Π½ΠΎΠΉ ΠΆΠ΅Π»Π΅Π·Ρ ΠΈ Π²Π΅Π½ΠΎΠ·Π½ΡΡ
ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½ΠΈΠΉ, ΠΈΠΌΠ΅ΡΡΠΈΡ
ΡΠ΅Π½Π΄Π΅Π½ΡΠΈΡ ΠΊ ΡΠΎΡΡΡ, Π½ΠΈΠ·ΠΊΠΈΠΉ ΡΡΠΎΠ²Π΅Π½Ρ Π±ΠΎΠ»Π΅Π·Π½Π΅ΠΉ ΠΌΠΎΡΠ΅ΠΏΠΎΠ»ΠΎΠ²ΠΎΠΉ ΡΠΈΡΡΠ΅ΠΌΡ, Π° ΡΠ°ΠΊΠΆΠ΅ ΡΠΎΡΡ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π΅ΠΌΠΎΡΡΠΈ ΠΏΡΠ΅ΡΠΊΠ»Π°ΠΌΠΏΡΠΈΠ΅ΠΉ, ΡΠΊΠ»Π°ΠΌΠΏΡΠΈΠ΅ΠΉ ΠΏΡΠΈ Π±ΠΎΠ»Π΅Π΅ Π½ΠΈΠ·ΠΊΠΎΠΉ ΠΎΠ±ΡΠ΅ΠΉ ΡΠ°ΡΡΠΎΡΠ΅ ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½ΠΈΠΉ Π±Π΅ΡΠ΅ΠΌΠ΅Π½Π½ΠΎΡΡΠΈ ΠΎΡΠ΅ΠΊΠ°ΠΌΠΈ, ΠΏΡΠΎΡΠ΅ΠΈΠ½ΡΡΠΈΠ΅ΠΉ ΠΈ Π³ΠΈΠΏΠ΅ΡΡΠ΅Π½Π·ΠΈΠ²Π½ΡΠΌΠΈ ΡΠ°ΡΡΡΡΠΎΠΉΡΡΠ²Π°ΠΌΠΈ. Π Π΅Π³ΠΈΠΎΠ½Π°Π»ΡΠ½ΡΠ΅ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΠΈ ΠΠ, ΠΊΠΎΡΠΎΡΡΠ΅ ΠΎΡΠ»ΠΈΡΠ°ΡΡ Π±ΠΎΠ»Π΅Π΅ Π½ΠΈΠ·ΠΊΡΡ ΡΠ°ΡΡΠΎΡΡ Π±ΠΎΠ»Π΅Π·Π½Π΅ΠΉ ΡΠΈΡΡΠ΅ΠΌΡ ΠΊΡΠΎΠ²ΠΎΠΎΠ±ΡΠ°ΡΠ΅Π½ΠΈΡ, Π²Π΅Π½ΠΎΠ·Π½ΡΡ
ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½ΠΈΠΉ ΠΈ ΡΡΠ°Π±ΠΈΠ»ΡΠ½ΠΎ Π½ΠΈΠ·ΠΊΠΈΠΉ ΡΡΠΎΠ²Π΅Π½Ρ ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½ΠΈΠΉ Π±Π΅ΡΠ΅ΠΌΠ΅Π½Π½ΠΎΡΡΠΈ ΠΏΡΠ΅ΡΠΊΠ»Π°ΠΌΠΏΡΠΈΠ΅ΠΉ, ΡΠΊΠ»Π°ΠΌΠΏΡΠΈΠ΅ΠΉ, Π² ΡΠ΅Π»ΠΎΠΌ Π² Π±ΠΎΠ»ΡΡΠ΅ΠΉ ΡΡΠ΅ΠΏΠ΅Π½ΠΈ ΠΎΡΡΠ°ΠΆΠ°ΡΡ ΠΎΠ±ΡΠ΅ΡΠΎΡΡΠΈΠΉΡΠΊΠΈΠ΅ ΡΠ΅Π½Π΄Π΅Π½ΡΠΈΠΈ. ΠΡΠΎΠ±Π»Π΅ΠΌΠ°ΠΌΠΈ, ΡΡΠ΅Π±ΡΡΡΠΈΠΌΠΈ ΠΏΡΠΈΠ½ΡΡΠΈΡ ΠΎΡΠ³Π°Π½ΠΈΠ·Π°ΡΠΈΠΎΠ½Π½ΡΡ
ΡΠ΅ΡΠ΅Π½ΠΈΠΉ, ΡΠ²Π»ΡΡΡΡΡ ΡΠ³ΡΠΎΠ·Π° ΠΏΡΠ΅ΡΡΠ²Π°Π½ΠΈΡ Π±Π΅ΡΠ΅ΠΌΠ΅Π½Π½ΠΎΡΡΠΈ, ΠΏΠΎΠ»ΠΎΠ²ΠΈΠ½Π° ΡΠ»ΡΡΠ°Π΅Π² ΠΊΠΎΡΠΎΡΠΎΠΉ, Π½Π΅Π·Π°Π²ΠΈΡΠΈΠΌΠΎ ΠΎΡ ΡΠ΅Π³ΠΈΠΎΠ½Π°, ΠΏΡΠΈΡ
ΠΎΠ΄ΠΈΡΡΡ Π½Π° ΡΡΠΎΠΊΠΈ 22β37 Π½Π΅Π΄Π΅Π»Ρ, ΠΈ ΡΠ°Ρ
Π°ΡΠ½ΡΠΉ Π΄ΠΈΠ°Π±Π΅Ρ, ΠΎΡΠ»ΠΎΠΆΠ½ΡΡΡΠΈΠΉ ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ Π³Π΅ΡΡΠ°ΡΠΈΠΈ, Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π΅ΠΌΠΎΡΡΡ ΠΊΠΎΡΠΎΡΡΠΌ Π² Π Π€ ΠΈ Π² ΠΠ Π½Π΅ΡΠΊΠ»ΠΎΠ½Π½ΠΎ ΡΠ°ΡΡΠ΅Ρ, Π° Π² ΠΠ§Π , Π½Π΅ΡΠΌΠΎΡΡΡ Π½Π° ΡΠ½ΠΈΠΆΠ΅Π½ΠΈΠ΅, ΡΠ°Π·Π±ΡΠΎΡ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Ρ Π²ΡΠ΅ Π΅ΡΠ΅ ΡΠΎΠΎΡΠ²Π΅ΡΡΡΠ²ΡΠ΅Ρ ΠΎΠ±ΡΠ΅ΡΠΎΡΡΠΈΠΉΡΠΊΠΎΠΌΡ
ΠΠΠΠ«ΠΠΠ¨ΠΠΠΠΠΠ ΠΠΠ ΠΠΠΠΠΠΠ‘Π’Π ΠΠΠ€ΠΠΠ¦ΠΠΠΠΠΠΠ ΠΠΠΠΠΠ: Π ΠΠΠΠ ΠΠ‘Π£ Π ΠΠ£ΠΠ‘ΠΠΠ Π€ΠΠΠ’ΠΠ Π
A huge number of men reproductive dysfunction causes are known, among which the leading position is up to urogenital tract infection. The aim of our study was to investigate the infectious factor of spermatogenesis lesions in 2198 men aged 24 to 52 years from couples with miscarriage. The results indicate the presence of pathospermia in 89.0% of the examined men, while asthenozoospermia (100%), an increase in the pH of the ejaculate medium to 7.9-8.0 (100%), and antisperm antibodies (91.9%), increased viscosity of ejaculate (63.3%), the presence of mucus and microflora (44.3%), teratozospermia (35.4%) were mainly diagnosed. In 60.5% of patients was diagnosed papillomavirus infection, in 39.5% - herpes virus; Cl.trahomatis was detected in 45.2%, Tr.vaginalis - in 4.8%, U. urealyticum - in 85.5%, and M. Hominis - in 43.5%. It is recommended that men are needed to be included in the mandatory algorithm for pregravid examination and treatment in families with miscarriage.ΠΠ·Π²Π΅ΡΡΠ½ΠΎ ΠΎΠ³ΡΠΎΠΌΠ½ΠΎΠ΅ ΠΊΠΎΠ»ΠΈΡΠ΅ΡΡΠ²ΠΎ ΠΏΡΠΈΡΠΈΠ½ Π½Π°ΡΡΡΠ΅Π½ΠΈΡ ΡΠ΅ΠΏΡΠΎΠ΄ΡΠΊΡΠΈΠ²Π½ΠΎΠΉ ΡΡΠ½ΠΊΡΠΈΠΈ Ρ ΠΌΡΠΆΡΠΈΠ½, ΡΡΠ΅Π΄ΠΈ ΠΊΠΎΡΠΎΡΡΡ
Π»ΠΈΠ΄ΠΈΡΡΡΡΠ΅Π΅ ΠΏΠΎΠ»ΠΎΠΆΠ΅Π½ΠΈΠ΅ Π·Π°Π½ΠΈΠΌΠ°Π΅Ρ ΠΈΠ½ΡΠΈΡΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅ ΡΡΠΎΠ³Π΅Π½ΠΈΡΠ°Π»ΡΠ½ΠΎΠ³ΠΎ ΡΡΠ°ΠΊΡΠ°. Π¦Π΅Π»ΡΡ Π½Π°ΡΠ΅Π³ΠΎ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ Π±ΡΠ»ΠΎ ΠΈΠ·ΡΡΠ΅Π½ΠΈΠ΅ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΎΠ½Π½ΠΎΠ³ΠΎ ΡΠ°ΠΊΡΠΎΡΠ° Π½Π°ΡΡΡΠ΅Π½ΠΈΡ ΡΠΏΠ΅ΡΠΌΠ°ΡΠΎΠ³Π΅Π½Π΅Π·Π° Ρ 2198 ΠΌΡΠΆΡΠΈΠ½ Π² Π²ΠΎΠ·ΡΠ°ΡΡΠ΅ ΠΎΡ 24 Π΄ΠΎ 52 Π»Π΅Ρ ΠΈΠ· ΠΏΠ°Ρ Ρ ΠΏΡΠΎΠ±Π»Π΅ΠΌΠΎΠΉ Π½Π΅Π²ΡΠ½Π°ΡΠΈΠ²Π°Π½ΠΈΡ Π±Π΅ΡΠ΅ΠΌΠ΅Π½Π½ΠΎΡΡΠΈ. Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ ΡΡΠΊΡΠ»ΡΡΠ° ΡΠ²ΠΈΠ΄Π΅ΡΠ΅Π»ΡΡΡΠ²ΡΡΡ ΠΎ Π½Π°Π»ΠΈΡΠΈΠΈ ΠΏΠ°ΡΠΎΡΠΏΠ΅ΡΠΌΠΈΠΈ Ρ 89,0% ΠΎΠ±ΡΠ»Π΅Π΄ΠΎΠ²Π°Π½Π½ΡΡ
ΠΌΡΠΆΡΠΈΠ½, ΠΏΡΠΈ ΡΡΠΎΠΌ ΠΏΡΠ΅ΠΈΠΌΡΡΠ΅ΡΡΠ²Π΅Π½Π½ΠΎ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΡΠΎΠ²Π°Π»ΠΈΡΡ Π°ΡΡΠ΅Π½ΠΎΠ·ΠΎΠΎΡΠΏΠ΅ΡΠΌΠΈΡ (100%), ΠΏΠΎΠ²ΡΡΠ΅Π½ΠΈΠΈ ΡΠ ΡΡΠ΅Π΄Ρ ΡΡΠΊΡΠ»ΡΡΠ° Π΄ΠΎ 7,9-8,0 (100%), Π°Π½ΡΠΈΡΠΏΠ΅ΡΠΌΠ°Π»ΡΠ½ΡΠ΅ Π°Π½ΡΠΈΡΠ΅Π»Π° (91,9%), ΠΏΠΎΠ²ΡΡΠ΅Π½ΠΈΠ΅ Π²ΡΠ·ΠΊΠΎΡΡΠΈ ΡΡΠΊΡΠ»ΡΡΠ° (63,3%), Π½Π°Π»ΠΈΡΠΈΠ΅ ΡΠ»ΠΈΠ·ΠΈ ΠΈ ΠΌΠΈΠΊΡΠΎΡΠ»ΠΎΡΡ (44,3%), ΡΠ΅ΡΠ°ΡΠΎΠ·ΠΎΡΠΏΠ΅ΡΠΌΠΈΡ (35,4%). Π£ 60,5% ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Π±ΡΠ»Π° Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΡΠΎΠ²Π°Π½Π° ΠΏΠ°ΠΏΠΈΠ»Π»ΠΎΠΌΠΎΠ²ΠΈΡΡΡΠ½Π°Ρ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΡ, Ρ 39,5% - Π³Π΅ΡΠΏΠ΅ΡΠ²ΠΈΡΡΡΠ½Π°Ρ; Ρ 45,2% Π±ΡΠ»Π° Π²ΡΡΠ²Π»Π΅Π½Π° Cl.trahomatis, Ρ 4,8% - Tr.vaginalis, Ρ 85,5% - U. Urealyticum, Ρ 43,5% - M. Hominis. Π£ Π²ΡΠ΅Ρ
ΠΎΠ±ΡΠ»Π΅Π΄ΠΎΠ²Π°Π½Π½ΡΡ
(100%) Π²ΡΡΠ²Π»Π΅Π½ΠΎ 2 ΠΈ Π±ΠΎΠ»Π΅Π΅ Π²ΠΎΠ·Π±ΡΠ΄ΠΈΡΠ΅Π»Π΅ΠΉ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΈ. Π Π΅ΠΊΠΎΠΌΠ΅Π½Π΄ΠΎΠ²Π°Π½ΠΎ Π²ΠΊΠ»ΡΡΠΈΡΡ ΠΌΡΠΆΡΠΈΠ½ Π² ΠΎΠ±ΡΠ·Π°ΡΠ΅Π»ΡΠ½ΡΠΉ Π°Π»Π³ΠΎΡΠΈΡΠΌ ΠΏΡΠ΅Π³ΡΠ°Π²ΠΈΠ΄Π°ΡΠ½ΠΎΠ³ΠΎ ΠΎΠ±ΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ ΠΈ Π»Π΅ΡΠ΅Π½ΠΈΡ Π² ΡΠ΅ΠΌΡΡΡ
Ρ Π½Π΅Π²ΡΠ½Π°ΡΠΈΠ²Π°Π½ΠΈΠ΅ΠΌ Π±Π΅ΡΠ΅ΠΌΠ΅Π½Π½ΠΎΡΡΠΈ
ΠΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ ΡΡΠΎΠ²Π½Ρ ΠΏΡΠΎΠ²ΠΎΡΠΏΠ°Π»ΠΈΡΠ΅Π»ΡΠ½ΡΡ ΡΠΈΡΠΎΠΊΠΈΠ½ΠΎΠ² Ρ ΠΆΠ΅Π½ΡΠΈΠ½ Ρ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡΠΌΠΈ ΡΠ΅ΠΉΠΊΠΈ ΠΌΠ°ΡΠΊΠΈ, Π°ΡΡΠΎΡΠΈΠΈΡΠΎΠ²Π°Π½Π½ΡΠΌΠΈ Ρ ΠΏΠ°ΠΏΠΈΠ»Π»ΠΎΠΌΠΎΠ²ΠΈΡΡΡΠ½ΠΎΠΉ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠ΅ΠΉ
Objective. The content of interferon-Ξ³ (IFN-y) and interleukins (IL) 13 and 17 in the serum of women with human papillomavirus infection was examined. Methods. 38 patients with chronic cervicitis associated with human papillomavirus infection (average age 26.2 years), including 18 - with pointed anogenital warts were observed. The control group - 10 healthy female volunteers. Cytokine levels were determined using specific reagents from R&D Diagnostics Inc. (USA) by the sandwich method of enzyme-linked immunosorbent assay. Results. The levels of IFN-Ξ³ and IL-17 in the serum increased, however, no significant differences between the groups examined in various clinical variants of human papillomavirus infection were found. The level of IL-13 in women with anogenital warts was twice as high as in patients without anogenital warts. Conclusions. The increase in the content of all cytokines presented in the study in the serum testified to the activation of the immune system. The high content of IL-13 in human papillomavirus infection can serve as a marker of a persistent inflammatory reaction that accompanies the development of warts.ΠΡΠ΅Π½ΠΈΠ²Π°Π»ΠΈ ΡΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅ ΠΈΠ½ΡΠ΅ΡΡΠ΅ΡΠΎΠ½Π°-Ξ³ (ΠΠ€Π-Ξ³) ΠΈ ΠΈΠ½ΡΠ΅ΡΠ»Π΅ΠΉΠΊΠΈΠ½ΠΎΠ² (ΠΠ) 13 ΠΈ 17 Π² ΡΡΠ²ΠΎΡΠΎΡΠΊΠ΅ ΠΊΡΠΎΠ²ΠΈ 38 ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠΊ Ρ ΠΏΠ°ΠΏΠΈΠ»Π»ΠΎΠΌΠ°Π²ΠΈΡΡΡΠ½ΠΎΠΉ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠ΅ΠΉ, Π² Ρ.Ρ. 18 - Ρ ΠΎΡΡΡΠΎΠΊΠΎΠ½Π΅ΡΠ½ΡΠΌΠΈ Π°Π½ΠΎΠ³Π΅Π½ΠΈΡΠ°Π»ΡΠ½ΡΠΌΠΈ ΠΊΠΎΠ½Π΄ΠΈΠ»ΠΎΠΌΠ°ΠΌΠΈ. Π£ΡΠΎΠ²Π½ΠΈ ΠΠ€Π-y ΠΈ ΠΠ-17 ΠΏΠΎΠ²ΡΡΠ°Π»ΠΈΡΡ, ΠΎΠ΄Π½Π°ΠΊΠΎ Π΄ΠΎΡΡΠΎΠ²Π΅ΡΠ½ΡΡ
ΡΠ°Π·Π»ΠΈΡΠΈΠΉ ΠΌΠ΅ΠΆΠ΄Ρ Π³ΡΡΠΏΠΏΠ°ΠΌΠΈ ΠΎΠ±ΡΠ»Π΅Π΄ΠΎΠ²Π°Π½Π½ΡΡ
ΠΏΡΠΈ ΡΠ°Π·Π½ΡΡ
ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΡ
Π²Π°ΡΠΈΠ°Π½ΡΠ°Ρ
ΠΏΠ°ΠΏΠΈΠ»Π»ΠΎΠΌΠ°Π²ΠΈΡΡΡΠ½ΠΎΠΉ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΈ Π²ΡΡΠ²Π»Π΅Π½ΠΎ Π½Π΅ Π±ΡΠ»ΠΎ. Π£ΡΠΎΠ²Π΅Π½Ρ ΠΠ-13 Ρ ΠΆΠ΅Π½ΡΠΈΠ½ Ρ Π°Π½ΠΎΠ³Π΅Π½ΠΈΡΠ°Π»ΡΠ½ΡΠΌΠΈ ΠΊΠΎΠ½Π΄ΠΈΠ»ΠΎΠΌΠ°ΠΌΠΈ ΠΎΠΊΠ°Π·Π°Π»ΡΡ Π²Π΄Π²ΠΎΠ΅ Π²ΡΡΠ΅, ΡΠ΅ΠΌ Ρ Π±ΠΎΠ»ΡΠ½ΡΡ
Π±Π΅Π· Π°Π½ΠΎΠ³Π΅Π½ΠΈΡΠ°Π»ΡΠ½ΡΡ
ΠΊΠΎΠ½Π΄ΠΈΠ»ΠΎΠΌ. ΠΠ΅Π»Π°Π΅ΡΡΡ Π²ΡΠ²ΠΎΠ΄, ΡΡΠΎ Π²ΡΡΠΎΠΊΠΎΠ΅ ΡΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅ ΠΠ-13 Π² ΡΡΠ²ΠΎΡΠΎΡΠΊΠ΅ ΠΊΡΠΎΠ²ΠΈ ΠΏΡΠΈ ΠΏΠ°ΠΏΠΈΠ»Π»ΠΎΠΌΠ°Π²ΠΈΡΡΡΠ½ΠΎΠΉ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΈ ΠΌΠΎΠΆΠ΅Ρ ΡΠ»ΡΠΆΠΈΡΡ ΠΌΠ°ΡΠΊΠ΅ΡΠΎΠΌ ΡΡΠΎΠΉΠΊΠΎΠΉ Π²ΠΎΡΠΏΠ°Π»ΠΈΡΠ΅Π»ΡΠ½ΠΎΠΉ ΡΠ΅Π°ΠΊΡΠΈΠΈ, ΡΠΎΠΏΡΠΎΠ²ΠΎΠΆΠ΄Π°ΡΡΠ΅ΠΉ ΡΠ°Π·Π²ΠΈΡΠΈΠ΅ ΠΊΠΎΠ½Π΄ΠΈΠ»ΠΎΠΌ
The role of male factor in pregnancy loss
Maternal and child health is recognized as a priority in healthcare. Miscarriage is the most common complication of the gestational period. Effectively solving the problem of reproductive losses is possible only at the stage of pregravid preparation of a married couple. Objective. To assess the participation of the male factor in studies of spermogram and cytokine profile in men. Materials and methods. A survey of 471 men from couples with fetal loss syndrome was conducted. The control group consists of 177 men from couples without reproductive losses. All patients underwent an andrological examination, including the assessment of sexual status with the determination of the volume and consistency of the testicles, digital rectal examination, questionnaires, which allow to assess the androgen status and sexual function. Examination for sexually transmitted infections was carried out according to generally accepted standards. Results. In men of the main groups, a statistically significant decrease in the total sperm motility, as well as the number of spermatozoa with progressive movement, was found. A significant decrease in the level of citric acid was recorded, which may indicate a significant inhibition of prostate function. During the examination of men, the incidence of pathospermia was 89% of cases. The leading causative factor of pathospermia is genital tract infection. Conclusion. In existing practice, the importance of sperm of men who have had a viral and chlamydial infection of the genital tract, as a source of infection of the sexual partner and the cause of reproductive loss, is underestimated. With true infectious genesis, there is no difference between spontaneous and habitual miscarriage, if the basis is a viral infection or a viral-bacterial association. Β© 2020, Media Sphera Publishing Group. All rights reserved
"Π’ΠΠΠΠΠ" ΠΠΠΠΠΠΠ’Π ΠΠ - Π‘ΠΠΠ ΠΠΠΠΠΠ«Π ΠΠΠΠΠ―Π ΠΠ ΠΠ ΠΠΠΠΠΠ£
This review is devoted to the analysis of the state of the problem of Β«thinΒ» endometrium. One of the main ways to solve the problem of overcoming reproductive failures includes the correction of endometrial dysfunction associated with a violation of endometrial receptivity and the reparative potential, called Β«thinΒ» endometrium. The features of the clinical manifestation and diagnosis of the syndrome of Β«thinΒ» endometrium are described; the principles of choice of therapy aimed at restoring the morphofunctional state of the endometrium are determined. Diagnostic possibilities regarding the endometrial receptivity are currently insufficient. Their search will allow to increase the effectiveness of overcoming reproductive failures associated with the syndrome of Β«thinΒ» endometrium in the futureΠΠ°ΡΡΠΎΡΡΠΈΠΉ ΠΎΠ±Π·ΠΎΡ ΠΏΠΎΡΠ²ΡΡΠ΅Π½ Π°Π½Π°Π»ΠΈΠ·Ρ ΡΠΎΡΡΠΎΡΠ½ΠΈΡ ΠΏΡΠΎΠ±Π»Π΅ΠΌΡ Β«ΡΠΎΠ½ΠΊΠΎΠ³ΠΎΒ» ΡΠ½Π΄ΠΎΠΌΠ΅ΡΡΠΈΡ. ΠΠ΄Π½ΠΈΠΌ ΠΈΠ· ΠΎΡΠ½ΠΎΠ²Π½ΡΡ
Π½Π°ΠΏΡΠ°Π²Π»Π΅Π½ΠΈΠΉ ΡΠ΅ΡΠ΅Π½ΠΈΡ ΠΏΡΠΎΠ±Π»Π΅ΠΌΡ ΠΏΡΠ΅ΠΎΠ΄ΠΎΠ»Π΅Π½ΠΈΡ ΡΠ΅ΠΏΡΠΎΠ΄ΡΠΊΡΠΈΠ²Π½ΡΡ
Π½Π΅ΡΠ΄Π°Ρ ΡΠ²Π»ΡΠ΅ΡΡΡ ΠΊΠΎΡΡΠ΅ΠΊΡΠΈΡ ΡΠ½Π΄ΠΎΠΌΠ΅ΡΡΠΈΠ°Π»ΡΠ½ΠΎΠΉ Π΄ΠΈΡΡΡΠ½ΠΊΡΠΈΠΈ, Π°ΡΡΠΎΡΠΈΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠΉ Ρ Π½Π°ΡΡΡΠ΅Π½ΠΈΠ΅ΠΌ ΡΠ΅ΡΠ΅ΠΏΡΠΈΠ²Π½ΠΎΡΡΠΈ ΠΈ ΡΠ΅ΠΏΠ°ΡΠ°ΡΠΈΠ²Π½ΠΎΠ³ΠΎ ΠΏΠΎΡΠ΅Π½ΡΠΈΠ°Π»Π° ΡΠ½Π΄ΠΎΠΌΠ΅ΡΡΠΈΡ, ΠΏΠΎΠ»ΡΡΠΈΠ²ΡΠ΅Π³ΠΎ Π½Π°Π·Π²Π°Π½ΠΈΠ΅ Β«ΡΠΎΠ½ΠΊΠΈΠΉΒ» ΡΠ½Π΄ΠΎΠΌΠ΅ΡΡΠΈΠΉ. ΠΠΏΠΈΡΠ°Π½Ρ ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΠΈ ΠΊΠ»ΠΈΠ½ΠΈΠΊΠΈ ΠΈ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ ΡΠΈΠ½Π΄ΡΠΎΠΌΠ° Β«ΡΠΎΠ½ΠΊΠΎΠ³ΠΎΒ» ΡΠ½Π΄ΠΎΠΌΠ΅ΡΡΠΈΡ, ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½Ρ ΠΏΡΠΈΠ½ΡΠΈΠΏΡ ΠΏΠΎΠ΄Π±ΠΎΡΠ° ΡΠ΅ΡΠ°ΠΏΠΈΠΈ, Π½Π°ΠΏΡΠ°Π²Π»Π΅Π½Π½ΠΎΠΉ Π½Π° Π²ΠΎΡΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½ΠΈΠ΅ ΠΌΠΎΡΡΠΎΡΡΠ½ΠΊΡΠΈΠΎΠ½Π°Π»ΡΠ½ΠΎΠ³ΠΎ ΡΠΎΡΡΠΎΡΠ½ΠΈΡ ΡΠ½Π΄ΠΎΠΌΠ΅ΡΡΠΈΡ. ΠΠΈΠ°Π³Π½ΠΎΡΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΠΈ Π² ΠΎΡΠ½ΠΎΡΠ΅Π½ΠΈΠΈ ΡΠ΅ΡΠ΅ΠΏΡΠΈΠ²Π½ΠΎΡΡΠΈ ΡΠ½Π΄ΠΎΠΌΠ΅ΡΡΠΈΡ Π² Π½Π°ΡΡΠΎΡΡΠ΅Π΅ Π²ΡΠ΅ΠΌΡ Π½Π΅Π΄ΠΎΡΡΠ°ΡΠΎΡΠ½Ρ. ΠΡ
ΠΏΠΎΠΈΡΠΊ ΠΏΠΎΠ·Π²ΠΎΠ»ΠΈΡ Π² Π±ΡΠ΄ΡΡΠ΅ΠΌ ΠΏΠΎΠ²ΡΡΠΈΡΡ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ ΠΏΡΠ΅ΠΎΠ΄ΠΎΠ»Π΅Π½ΠΈΡ ΡΠ΅ΠΏΡΠΎΠ΄ΡΠΊΡΠΈΠ²Π½ΡΡ
Π½Π΅ΡΠ΄Π°Ρ, Π°ΡΡΠΎΡΠΈΠΈΡΠΎΠ²Π°Π½Π½ΡΡ
Ρ ΡΠΈΠ½Π΄ΡΠΎΠΌΠΎΠΌ Β«ΡΠΎΠ½ΠΊΠΎΠ³ΠΎΒ» ΡΠ½Π΄ΠΎΠΌΠ΅ΡΡΠΈΡ
ΠΠ΅Π½ΠΈΡΠ°Π»ΡΠ½ΡΠΉ Π³Π΅ΡΠΏΠ΅Ρ Π² ΠΏΡΠ°ΠΊΡΠΈΠΊΠ΅ Π³ΠΈΠ½Π΅ΠΊΠΎΠ»ΠΎΠ³Π°: ΡΠ»ΠΎΠΆΠ½ΡΠ΅ Π²ΠΎΠΏΡΠΎΡΡ - ΠΏΡΠΎΡΡΡΠ΅ ΠΎΡΠ²Π΅ΡΡ
Among specific genital infections, genital herpes (GH) takes a special place. For a gynecologist, aspects of timely diagnosis and therapy are of prime importance, including possibility of an atypical course of the disease and virus transmission through sexual encounter from asymptomatic carriers, since GH creates opportunities for viral invasion into tissues of endometrium, increases risks of miscarriage and failure to become pregnant after in vitro fertilization. Algorithms for management of patient or married couples shall comply with current clinical practice guidelines. At a fundamental level of GH therapy there is nucleoside analogues usage, which can reduce the period of clinical implications (episodic therapy), as well as reduce number of disease recurrences and viral transmission probability (suppressive therapy). Evidence-based data suggests that valaciclovir usage (second generation' acyclic nucleoside) allow to reduce effective daily dose, reverse HG symptoms faster, prolong delaying time to relapse, increase compliance and safety of therapy. All of this makes valaciclovir the drug of choice if suppressive therapy, including long-term therapy is necessary. When managing patients with GH, especially with an atypical or asymptomatic disease, it is necessary to inform them about features of the infection course and importance for examination and treatment of sex partners, as well as about therapy which is aimed at primary prevention of viral transmission and reducing number of disease recurrences.Π‘ΡΠ΅Π΄ΠΈ ΡΠΏΠ΅ΡΠΈΡΠΈΡΠ΅ΡΠΊΠΈΡ
Π³Π΅Π½ΠΈΡΠ°Π»ΡΠ½ΡΡ
ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΉ ΠΎΡΠΎΠ±ΠΎΠ΅ ΠΌΠ΅ΡΡΠΎ Π·Π°Π½ΠΈΠΌΠ°Π΅Ρ Π³Π΅Π½ΠΈΡΠ°Π»ΡΠ½ΡΠΉ Π³Π΅ΡΠΏΠ΅Ρ (ΠΠ). ΠΠ»Ρ Π³ΠΈΠ½Π΅ΠΊΠΎΠ»ΠΎΠ³Π° ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎ Π²Π°ΠΆΠ½Ρ Π°ΡΠΏΠ΅ΠΊΡΡ ΡΠ²ΠΎΠ΅Π²ΡΠ΅ΠΌΠ΅Π½Π½ΠΎΠΉ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ ΠΈ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ, Π² ΡΠΎΠΌ ΡΠΈΡΠ»Π΅ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΡ Π°ΡΠΈΠΏΠΈΡΠ½ΠΎΠ³ΠΎ ΡΠ΅ΡΠ΅Π½ΠΈΡ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ ΠΈ ΠΏΠ΅ΡΠ΅Π΄Π°ΡΠΈ Π²ΠΈΡΡΡΠ° ΠΏΡΠΈ ΠΏΠΎΠ»ΠΎΠ²ΠΎΠΌ ΠΊΠΎΠ½ΡΠ°ΠΊΡΠ΅ ΠΎΡ Π±Π΅ΡΡΠΈΠΌΠΏΡΠΎΠΌΠ½ΠΎΠ³ΠΎ Π½ΠΎΡΠΈΡΠ΅Π»Ρ, ΠΏΠΎΡΠΊΠΎΠ»ΡΠΊΡ ΠΠ ΡΠΎΠ·Π΄Π°Π΅Ρ ΠΏΡΠ΅Π΄ΠΏΠΎΡΡΠ»ΠΊΠΈ ΠΊ Π²ΠΈΡΡΡΠ½ΠΎΠΉ ΠΈΠ½Π²Π°Π·ΠΈΠΈ ΡΠ½Π΄ΠΎΠΌΠ΅ΡΡΠΈΡ, ΠΏΠΎΠ²ΡΡΠ°Π΅Ρ ΡΠΈΡΠΊΠΈ Π½Π΅Π²ΡΠ½Π°ΡΠΈΠ²Π°Π½ΠΈΡ Π±Π΅ΡΠ΅ΠΌΠ΅Π½Π½ΠΎΡΡΠΈ ΠΈ Π½Π΅ΡΠ΄Π°Ρ ΡΠΊΡΡΡΠ°ΠΊΠΎΡΠΏΠΎΡΠ°Π»ΡΠ½ΠΎΠ³ΠΎ ΠΎΠΏΠ»ΠΎΠ΄ΠΎΡΠ²ΠΎΡΠ΅Π½ΠΈΡ. ΠΠ»Π³ΠΎΡΠΈΡΠΌΡ Π²Π΅Π΄Π΅Π½ΠΈΡ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠΊ ΠΈΠ»ΠΈ ΡΡΠΏΡΡΠΆΠ΅ΡΠΊΠΈΡ
ΠΏΠ°Ρ Π΄ΠΎΠ»ΠΆΠ½Ρ ΡΠΎΠΎΡΠ²Π΅ΡΡΡΠ²ΠΎΠ²Π°ΡΡ Π΄Π΅ΠΉΡΡΠ²ΡΡΡΠΈΠΌ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΠΌ ΡΠ΅ΠΊΠΎΠΌΠ΅Π½Π΄Π°ΡΠΈΡΠΌ. Π ΠΎΡΠ½ΠΎΠ²Π΅ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ ΠΠ Π»Π΅ΠΆΠΈΡ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ Π°Π½Π°Π»ΠΎΠ³ΠΎΠ² Π½ΡΠΊΠ»Π΅ΠΎΠ·ΠΈΠ΄ΠΎΠ², ΠΏΠΎΠ·Π²ΠΎΠ»ΡΡΡΠΈΡ
ΡΠΎΠΊΡΠ°ΡΠΈΡΡ ΠΏΠ΅ΡΠΈΠΎΠ΄ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΏΡΠΎΡΠ²Π»Π΅Π½ΠΈΡ (ΡΠΏΠΈΠ·ΠΎΠ΄ΠΈΡΠ΅ΡΠΊΠ°Ρ ΡΠ΅ΡΠ°ΠΏΠΈΡ), Π° ΡΠ°ΠΊΠΆΠ΅ ΡΠ½ΠΈΠ·ΠΈΡΡ ΡΠΈΡΠ»ΠΎ ΡΠ΅ΡΠΈΠ΄ΠΈΠ²ΠΎΠ² ΠΈ Π²Π΅ΡΠΎΡΡΠ½ΠΎΡΡΡ ΠΏΠ΅ΡΠ΅Π΄Π°ΡΠΈ Π²ΠΈΡΡΡΠ° ΠΏΠ°ΡΡΠ½Π΅ΡΡ (ΡΡΠΏΡΠ΅ΡΡΠΈΠ²Π½Π°Ρ ΡΠ΅ΡΠ°ΠΏΠΈΡ). ΠΠ°Π½Π½ΡΠ΅, ΠΎΡΠ½ΠΎΠ²Π°Π½Π½ΡΠ΅ Π½Π° Π΄ΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΡΡΡΠ²Π°Ρ
, ΡΠ²ΠΈΠ΄Π΅ΡΠ΅Π»ΡΡΡΠ²ΡΡΡ, ΡΡΠΎ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ Π°ΡΠΈΠΊΠ»ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ Π½ΡΠΊΠ»Π΅ΠΎΠ·ΠΈΠ΄Π° II ΠΏΠΎΠΊΠΎΠ»Π΅Π½ΠΈΡ Π²Π°Π»Π°ΡΠΈΠΊΠ»ΠΎΠ²ΠΈΡΠ° ΠΏΠΎΠ·Π²ΠΎΠ»ΡΠ΅Ρ ΡΠΌΠ΅Π½ΡΡΠΈΡΡ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΡΡ ΡΡΡΠΎΡΠ½ΡΡ Π΄ΠΎΠ·Ρ, Π±ΡΡΡΡΠ΅Π΅ ΠΊΡΠΏΠΈΡΠΎΠ²Π°ΡΡ ΡΠΈΠΌΠΏΡΠΎΠΌΡ ΠΠ, ΠΏΡΠΎΠ»ΠΎΠ½Π³ΠΈΡΠΎΠ²Π°ΡΡ Π±Π΅Π·ΡΠ΅ΡΠΈΠ΄ΠΈΠ²Π½ΡΠΉ ΠΏΠ΅ΡΠΈΠΎΠ΄, ΠΏΠΎΠ²ΡΡΠΈΡΡ ΠΊΠΎΠΌΠΏΠ»Π°ΠΉΠ΅Π½ΡΠ½ΠΎΡΡΡ ΠΈ Π±Π΅Π·ΠΎΠΏΠ°ΡΠ½ΠΎΡΡΡ Π»Π΅ΡΠ΅Π½ΠΈΡ, ΡΡΠΎ Π΄Π΅Π»Π°Π΅Ρ Π΅Π³ΠΎ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠΎΠΌ Π²ΡΠ±ΠΎΡΠ° ΠΏΡΠΈ Π½Π΅ΠΎΠ±Ρ
ΠΎΠ΄ΠΈΠΌΠΎΡΡΠΈ ΡΡΠΏΡΠ΅ΡΡΠΈΠ²Π½ΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ, Π² ΡΠΎΠΌ ΡΠΈΡΠ»Π΅ Π΄Π»ΠΈΡΠ΅Π»ΡΠ½ΠΎΠΉ. ΠΡΠΈ Π²Π΅Π΄Π΅Π½ΠΈΠΈ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠΊ Ρ ΠΠ, ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎ ΠΏΡΠΈ Π°ΡΠΈΠΏΠΈΡΠ½ΠΎΠΌ ΠΈΠ»ΠΈ Π±Π΅ΡΡΠΈΠΌΠΏΡΠΎΠΌΠ½ΠΎΠΌ ΡΠ΅ΡΠ΅Π½ΠΈΠΈ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΈ, ΠΎΠ±ΡΠ·Π°ΡΠ΅Π»ΡΠ½ΠΎ ΠΈΡ
ΠΈΠ½ΡΠΎΡΠΌΠΈΡΠΎΠ²Π°ΡΡ ΠΎΠ± ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΡΡ
ΡΠ΅ΡΠ΅Π½ΠΈΡ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΈ ΠΈ Π½Π΅ΠΎΠ±Ρ
ΠΎΠ΄ΠΈΠΌΠΎΡΡΠΈ ΠΎΠ±ΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ ΠΈ Π»Π΅ΡΠ΅Π½ΠΈΡ ΠΏΠΎΠ»ΠΎΠ²ΡΡ
ΠΏΠ°ΡΡΠ½Π΅ΡΠΎΠ², Π° ΡΠ°ΠΊΠΆΠ΅ ΠΎ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ, Π½Π°ΠΏΡΠ°Π²Π»Π΅Π½Π½ΠΎΠΉ Π½Π° ΠΏΠ΅ΡΠ²ΠΈΡΠ½ΡΡ ΠΏΡΠΎΡΠΈΠ»Π°ΠΊΡΠΈΠΊΡ ΠΏΠ΅ΡΠ΅Π΄Π°ΡΠΈ Π²ΠΈΡΡΡΠ° ΠΈ ΡΠΎΠΊΡΠ°ΡΠ΅Π½ΠΈΠ΅ ΡΠΈΡΠ»Π° ΡΠ΅ΡΠΈΠ΄ΠΈΠ²ΠΎΠ²
Results of a multicenter observational study: Therapy for acute non-specific and mixed vaginitis in reproductive-aged patients
Objective. To evaluate the clinical and laboratory efficiency of two-step therapy with Depantol and Femilex for acute nonspecific and mixed vaginitis. Subjects and methods. The prospective observational study enrolled 200 patients aged 18-45 years with acute nonspecific and mixed (bacterial-fungal) vaginitis, who were stratified according to the diagnosis and the presence of pregnancy. All the patients underwent pH measurements over time and microscopic and molecular biological studies of vaginal discharge using the femoflor test, by evaluating microbiocenosis. Vaginitis therapy included Depantol as 1 vaginal suppository twice daily for 7 days, then Femilex as 1 vaginal suppository daily for 10 days. Descriptive statistical methods; one-way analysis of variance; a test for difference in proportions and means; Studentβs t-test; a chi-square (Ο2 ) test; and a paired Wilcoxon test were used in the analysis. The differences were considered significant at p <0.05. Results. Depantol and Femilex used for two-step therapy for acute nonspecific and mixed vaginitis achieved a clinical and laboratory efficiency of 91% and there were no significant differences between non-pregnant and pregnant women. The recurrence rate for vaginitis after two-month follow-up is determined by accompanying risk factors and does not exceed 3%. Conclusion. The sequential use of Depantol vaginal suppositories for 7 days and Femilex vaginal suppositories for 10 days is an effective two-step treatment regimen for acute nonspecific and mixed (bacterial-fungal) vaginitis in reproductive-aged women, which allows restoration of normocenosis in more than 90% of patients. Β© 2019, Bionika Media Ltd.. All rights reserved
"Π’ΠΠΠΠΠ" ΠΠΠΠΠΠΠ’Π ΠΠ - Π‘ΠΠΠ ΠΠΠΠΠΠ«Π ΠΠΠΠΠ―Π ΠΠ ΠΠ ΠΠΠΠΠΠ£
This review is devoted to the analysis of the state of the problem of Β«thinΒ» endometrium. One of the main ways to solve the problem of overcoming reproductive failures includes the correction of endometrial dysfunction associated with a violation of endometrial receptivity and the reparative potential, called Β«thinΒ» endometrium. The features of the clinical manifestation and diagnosis of the syndrome of Β«thinΒ» endometrium are described; the principles of choice of therapy aimed at restoring the morphofunctional state of the endometrium are determined. Diagnostic possibilities regarding the endometrial receptivity are currently insufficient. Their search will allow to increase the effectiveness of overcoming reproductive failures associated with the syndrome of Β«thinΒ» endometrium in the futureΠΠ°ΡΡΠΎΡΡΠΈΠΉ ΠΎΠ±Π·ΠΎΡ ΠΏΠΎΡΠ²ΡΡΠ΅Π½ Π°Π½Π°Π»ΠΈΠ·Ρ ΡΠΎΡΡΠΎΡΠ½ΠΈΡ ΠΏΡΠΎΠ±Π»Π΅ΠΌΡ Β«ΡΠΎΠ½ΠΊΠΎΠ³ΠΎΒ» ΡΠ½Π΄ΠΎΠΌΠ΅ΡΡΠΈΡ. ΠΠ΄Π½ΠΈΠΌ ΠΈΠ· ΠΎΡΠ½ΠΎΠ²Π½ΡΡ
Π½Π°ΠΏΡΠ°Π²Π»Π΅Π½ΠΈΠΉ ΡΠ΅ΡΠ΅Π½ΠΈΡ ΠΏΡΠΎΠ±Π»Π΅ΠΌΡ ΠΏΡΠ΅ΠΎΠ΄ΠΎΠ»Π΅Π½ΠΈΡ ΡΠ΅ΠΏΡΠΎΠ΄ΡΠΊΡΠΈΠ²Π½ΡΡ
Π½Π΅ΡΠ΄Π°Ρ ΡΠ²Π»ΡΠ΅ΡΡΡ ΠΊΠΎΡΡΠ΅ΠΊΡΠΈΡ ΡΠ½Π΄ΠΎΠΌΠ΅ΡΡΠΈΠ°Π»ΡΠ½ΠΎΠΉ Π΄ΠΈΡΡΡΠ½ΠΊΡΠΈΠΈ, Π°ΡΡΠΎΡΠΈΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠΉ Ρ Π½Π°ΡΡΡΠ΅Π½ΠΈΠ΅ΠΌ ΡΠ΅ΡΠ΅ΠΏΡΠΈΠ²Π½ΠΎΡΡΠΈ ΠΈ ΡΠ΅ΠΏΠ°ΡΠ°ΡΠΈΠ²Π½ΠΎΠ³ΠΎ ΠΏΠΎΡΠ΅Π½ΡΠΈΠ°Π»Π° ΡΠ½Π΄ΠΎΠΌΠ΅ΡΡΠΈΡ, ΠΏΠΎΠ»ΡΡΠΈΠ²ΡΠ΅Π³ΠΎ Π½Π°Π·Π²Π°Π½ΠΈΠ΅ Β«ΡΠΎΠ½ΠΊΠΈΠΉΒ» ΡΠ½Π΄ΠΎΠΌΠ΅ΡΡΠΈΠΉ. ΠΠΏΠΈΡΠ°Π½Ρ ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΠΈ ΠΊΠ»ΠΈΠ½ΠΈΠΊΠΈ ΠΈ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ ΡΠΈΠ½Π΄ΡΠΎΠΌΠ° Β«ΡΠΎΠ½ΠΊΠΎΠ³ΠΎΒ» ΡΠ½Π΄ΠΎΠΌΠ΅ΡΡΠΈΡ, ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½Ρ ΠΏΡΠΈΠ½ΡΠΈΠΏΡ ΠΏΠΎΠ΄Π±ΠΎΡΠ° ΡΠ΅ΡΠ°ΠΏΠΈΠΈ, Π½Π°ΠΏΡΠ°Π²Π»Π΅Π½Π½ΠΎΠΉ Π½Π° Π²ΠΎΡΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½ΠΈΠ΅ ΠΌΠΎΡΡΠΎΡΡΠ½ΠΊΡΠΈΠΎΠ½Π°Π»ΡΠ½ΠΎΠ³ΠΎ ΡΠΎΡΡΠΎΡΠ½ΠΈΡ ΡΠ½Π΄ΠΎΠΌΠ΅ΡΡΠΈΡ. ΠΠΈΠ°Π³Π½ΠΎΡΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΠΈ Π² ΠΎΡΠ½ΠΎΡΠ΅Π½ΠΈΠΈ ΡΠ΅ΡΠ΅ΠΏΡΠΈΠ²Π½ΠΎΡΡΠΈ ΡΠ½Π΄ΠΎΠΌΠ΅ΡΡΠΈΡ Π² Π½Π°ΡΡΠΎΡΡΠ΅Π΅ Π²ΡΠ΅ΠΌΡ Π½Π΅Π΄ΠΎΡΡΠ°ΡΠΎΡΠ½Ρ. ΠΡ
ΠΏΠΎΠΈΡΠΊ ΠΏΠΎΠ·Π²ΠΎΠ»ΠΈΡ Π² Π±ΡΠ΄ΡΡΠ΅ΠΌ ΠΏΠΎΠ²ΡΡΠΈΡΡ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ ΠΏΡΠ΅ΠΎΠ΄ΠΎΠ»Π΅Π½ΠΈΡ ΡΠ΅ΠΏΡΠΎΠ΄ΡΠΊΡΠΈΠ²Π½ΡΡ
Π½Π΅ΡΠ΄Π°Ρ, Π°ΡΡΠΎΡΠΈΠΈΡΠΎΠ²Π°Π½Π½ΡΡ
Ρ ΡΠΈΠ½Π΄ΡΠΎΠΌΠΎΠΌ Β«ΡΠΎΠ½ΠΊΠΎΠ³ΠΎΒ» ΡΠ½Π΄ΠΎΠΌΠ΅ΡΡΠΈΡ